BlackRock’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3K | Sell |
|
|||||
|
2025
Q1 | $130K | Sell |
|
|||||
|
2024
Q4 | $279K | Buy |
|
|||||
|
2024
Q3 | $156K | Buy |
|
|||||
|
2024
Q2 | $119K | Buy |
|
|||||
|
2024
Q1 | $137K | Sell |
|
|||||
|
2023
Q4 | $110K | Buy |
|
|||||
|
2023
Q3 | $182K | Sell |
|
|||||
|
2023
Q2 | $201K | Hold |
|
|||||
|
2023
Q1 | $151K | Sell |
|
|||||
|
2022
Q4 | $133K | Sell |
|
|||||
|
2022
Q3 | $197K | Sell |
|
|||||
|
2022
Q2 | $346K | Sell |
|
|||||
|
2022
Q1 | $652K | Sell |
|
|||||
|
2021
Q4 | $1.03M | Sell |
|
|||||
|
2021
Q3 | $1.44M | Sell |
|
|||||
|
2021
Q2 | $3.64M | Sell |
|
|||||
|
2021
Q1 | $24.7M | Buy |
|
|||||
|
2020
Q4 | $18.9M | Buy |
|
|||||
|
2020
Q3 | $16.3M | Buy |
|
|||||
|
2020
Q2 | $14.2M | Buy |
|
|||||
|
2020
Q1 | $7.94M | Buy |
|
|||||
|
2019
Q4 | $4.44M | Buy |
|
|||||
|
2019
Q3 | $4.24M | Buy |
|
|||||
|
2019
Q2 | $5.47M | Buy |
|
|||||
|
2019
Q1 | $4.95M | Buy |
|
|||||
|
2018
Q4 | $2.27M | Buy |
|
|||||
|
2018
Q3 | $5.2M | Buy |
|
|||||
|
2018
Q2 | $3.68M | Sell |
|
|||||
|
2018
Q1 | $17.2M | Buy |
|